Delivery Order #SPE2D326F6613

Naloxone Delivery Order Under Long-Term Pharmaceutical Manufacturing Contract

This award is a delivery order contract granted to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical manufacturing and distribution. The contract involves the procurement of Naloxone 2 mg/2 ml syringes, a critical opioid overdose reversal medication. This order supports the ongoing effort to maintain an adequate supply of essential injectable medications for emergency medical use. The scope of work includes the manufacture and delivery of these syringes within a short performance window, ensuring timely availability. This delivery order is part of a larger, multi-year indefinite delivery/indefinite quantity (IDIQ) contract that DMS Pharmaceutical Group holds, which covers a broad range of injectable pharmaceuticals distributed to meet government healthcare needs. The procurement’s significance lies in sustaining public health and emergency readiness by securing life-saving drugs. The contract was awarded as a supplementary order under the existing IDIQ contract, providing flexibility to meet demand without additional solicitation. The delivery order was performed over a concise timeframe, indicating a prompt fulfillment schedule. This award exemplifies continued collaboration between the government and DMS Pharmaceutical Group to maintain the supply chain of vital pharmaceutical products.

Description

4570964132!NALOXONE 2 MG/2 ML SYRINGE 2ML

View original record